DocebenoneAlternative Names: A 61589; AA 861
Latest Information Update: 24 Jan 2013
At a glance
- Originator Takeda
- Class Antiallergics; Antiasthmatics; Antiulcers; Benzoquinones; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors; Lipoxygenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma; Cancer; Gastric damage